GLP-1 Prior Authorization — How to Get Approved (2026)
Published 2026-07-01 · Updated 2026-07-08 · MetaDose Research
Free comparison
Compare GLP-1 providers & cash-pay options
See telehealth and pharmacy programs that may lower your monthly cost.
MetaDose may earn a fee through partner links. See our disclaimer.
Prior authorization is the operational bottleneck between “my doctor prescribed Wegovy” and “the pharmacy can bill $25.” In 2026 most commercial obesity benefits and many diabetes tiers still require PA. Approvals hinge on chart evidence, not persuasion. Denials are common on the first pass; complete packets reverse most of them.
The approval packet (what reviewers open)
- BMI ≥30, or ≥27 with comorbidity — logged from a real visit (see BMI requirements)
- Comorbidity ICD codes: HTN, OSA, dyslipidemia, prediabetes, PCOS as applicable
- 6–12 months of lifestyle or program notes (screenshots of apps rarely count alone)
- Labs when diabetes-indicated (A1C, sometimes lipids)
- Prescriber letter of medical necessity citing the plan’s own policy language
- Step-therapy attestations or contraindication notes — step therapy guide
Timeline and bridge-fill math
Standard review: roughly 3–14 business days; expedited exists for true urgency. Start PA before your pen empties. Bridge cash fills during review are a major hidden cost — one month of brand cash can erase a year of $25-card savings. Model that bridge in Affordability Audit.
If the first PA is denied
Do not restart from zero with a new e-script alone. Read the reason code, request criteria, fix the missing document, then file appeal or peer-to-peer. Full sequence: insurance denial appeal.
GLP-1 cost by state
Frequently Asked Questions
Can my doctor speed up prior auth?
They can request expedited review when clinically appropriate and submit a complete packet the first time — incomplete “rush” files still deny.
Does telehealth BMI count?
Some plans accept video visits with weight on the chart; others insist on in-person measurements. Check your plan’s medical policy.